Spot Biosystems
Pioneering non-viral extracellular vesicle gene therapy
Boston, United States · Founded 2023 · $40.0M raised
- Headquarters
- Boston
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- spotbiosystems.com
- Total Funding
- $40.0M
- Last Round
- $40.0M SeedJun 2026
- Rounds
- 1
About
Spot Biosystems is building the next generation of non-viral gene therapy using an extracellular vesicle (EV) delivery platform. Its technology enables safe, repeatable delivery of genetic medicines that viral vectors cannot carry, avoiding viral immunogenicity and toxicity. The lead program targets Duchenne muscular dystrophy and has entered human clinical trials with early signs of dystrophin restoration.
Summary
Spot Biosystems is a Biotech company based in Boston, United States, founded in 2023. It has raised $40.0M in total across 1 round, most recently a $40.0M Seed round in Jun 2026.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2026
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/spot-biosystems"><img src="https://indexed.vc/api/badge/company/spot-biosystems" alt="Spot Biosystems on Indexed.vc" width="260" height="76" /></a>